“Efficacy of Generic Bortezomib Used As a Part of CyBorD Regimen to Achieve Complete Response in Multiple Myeloma”. Innovative Journal of Medical and Health Sciences 9, no. 1 (February 4, 2019): 247–251. Accessed October 23, 2026. http://innovativejournal.in/index.php/ijmhs/article/view/2431.